The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...

“Viral and bacterial infectious causes of common dementias have been proposed, supported by epidemiological data linking ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

Anti-inflammatory drugs like ibuprofen, along with antibiotics, antiviral medications, and vaccines are associated with a ...

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, ...

Kyung Bo Kim discovered compounds that improved cognitive function regardless of amyloid plaque buildup — an encouraging sign ...

Findings from a large-scale review indicate certain medications may influence dementia risk, offering insights for prevention ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Patients and care partners may find once every four weeks maintenance dosing easier The US Food and Drug Administration (FDA ... maintenance dosing of LEQEMBI (lecanemab-irmb) for early Alzheimer’s ...